Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
about
Effect of Cardiac Resynchronization Therapy on Inflammation in Congestive Heart Failure: A ReviewAssociations of gut-flora-dependent metabolite trimethylamine-N-oxide, betaine and choline with non-alcoholic fatty liver disease in adults.Intestinal Microbiota Metabolism and AtherosclerosisNon-lethal Inhibition of Gut Microbial Trimethylamine Production for the Treatment of AtherosclerosisElevated trimethylamine-N-oxide (TMAO) is associated with poor prognosis in primary sclerosing cholangitis patients with normal liver function.Microbiota-dependent metabolite and cardiovascular disease marker trimethylamine-N-oxide (TMAO) is associated with monocyte activation but not platelet function in untreated HIV infection.The changes of gut microbiota after acute myocardial infarction in rats.Intestinal microbiota composition modulates choline bioavailability from diet and accumulation of the proatherogenic metabolite trimethylamine-N-oxideStructure and Function of CutC Choline Lyase from Human Microbiota Bacterium Klebsiella pneumoniae.Serum Trimethylamine-N-Oxide Is Strongly Related to Renal Function and Predicts Outcome in Chronic Kidney DiseaseBrief Report: Intestinal Microbiota-Produced Trimethylamine-N-Oxide and Its Association With Coronary Stenosis and HIV Serostatus.Gut Microbial Metabolite TMAO Enhances Platelet Hyperreactivity and Thrombosis RiskA Phospholipid-Protein Complex from Antarctic Krill Reduced Plasma Homocysteine Levels and Increased Plasma Trimethylamine-N-Oxide (TMAO) and Carnitine Levels in Male Wistar Rats.HIV-infected persons with type 2 diabetes show evidence of endothelial dysfunction and increased inflammationTargeting of microbe-derived metabolites to improve human health: The next frontier for drug discovery.Trimethylamine N-Oxide Promotes Vascular Inflammation Through Signaling of Mitogen-Activated Protein Kinase and Nuclear Factor-κB.Major Increase in Microbiota-Dependent Proatherogenic Metabolite TMAO One Year After Bariatric Surgery.Intestinal Microbiota-Generated Metabolite Trimethylamine-N-Oxide and 5-Year Mortality Risk in Stable Coronary Artery Disease: The Contributory Role of Intestinal Microbiota in a COURAGE-Like Patient Cohort.Associations among serum trimethylamine-N-oxide (TMAO) levels, kidney function and infarcted coronary artery number in patients undergoing cardiovascular surgery: a cross-sectional studyMicrobiota-Dependent Metabolite Trimethylamine N-Oxide and Coronary Artery Calcium in the Coronary Artery Risk Development in Young Adults Study (CARDIA)Revised computational metagenomic processing uncovers hidden and biologically meaningful functional variation in the human microbiome.Egg Consumption and Incidence of Heart Failure: A Meta-Analysis of Prospective Cohort Studies.Circulating trimethylamine N-oxide and the risk of cardiovascular diseases: a systematic review and meta-analysis of 11 prospective cohort studies.Dietary Choline and Betaine and Risk of CVD: A Systematic Review and Meta-Analysis of Prospective StudiesGut Microbiota Metabolites and Risk of Major Adverse Cardiovascular Disease Events and Death: A Systematic Review and Meta-Analysis of Prospective Studies.Uncovering the trimethylamine-producing bacteria of the human gut microbiota.New Insight into the Dietary Cause of Atherosclerosis: Implications for Pharmacology.Microbiome, trimethylamine N-oxide, and cardiometabolic disease.Targeting the Microbiome in Heart Failure.Understanding the Holobiont: How Microbial Metabolites Affect Human Health and Shape the Immune System.Aberrant fecal flora observed in guinea pigs with pressure overload is mitigated in animals receiving vagus nerve stimulation therapy.Trimethylamine N-oxide: breathe new life.Gut Microbiota and Atherosclerosis.Gut microbiota and acute coronary syndromes: ready for use in the emergency room?Trimethylamine N-oxide and prognosis in acute heart failure.Novel Concept of a Heart-Gut Axis in the Pathophysiology of Heart Failure.Role of Gut Microbiota on Cardio-Metabolic Parameters and Immunity in Coronary Artery Disease Patients with and without Type-2 Diabetes MellitusThe TMAO-Producing Enzyme Flavin-Containing Monooxygenase 3 Regulates Obesity and the Beiging of White Adipose Tissue.Balancing Herbal Medicine and Functional Food for Prevention and Treatment of Cardiometabolic Diseases through Modulating Gut Microbiota.Intermittent Hypoxia and Hypercapnia Accelerate Atherosclerosis, Partially via Trimethylamine-Oxide.
P2860
Q27023183-6AB2331C-1E31-45BD-985E-444373ED5913Q27302142-71923F05-76F8-42F7-BF79-6F937C51155AQ28081862-BD6F526D-571B-4089-90B3-F2280EC809E8Q29038812-98FB5358-07EF-4AF2-8CCB-B4C155A0189AQ33731986-FA0C1575-478C-4735-AC72-743646EEB3D9Q33827624-F053D42C-4F7E-4424-8E01-381A8C0C5B25Q33884243-E567038B-46E9-4E00-8255-B8D424EF4EF6Q35580187-1B67A0E8-53DE-49FD-A026-2F46F7ABBA4AQ35695648-B59E726A-E533-4A82-AC81-2B7DB6A14A47Q35889821-030E212F-CD1D-4B60-B4CB-E39B7C4119FCQ35908640-0082D32A-8B3F-4451-ABD3-A495FC1AB7A8Q35955435-70BFF248-BBE5-4730-9B9E-3949E857CA54Q36096546-3BDA9F1D-97AE-4A0B-943B-FDC8448AFFEBQ36327164-A07A7A67-938C-4B7D-91A5-662822FB22C9Q36340545-CB86A323-D043-4CD2-BD0A-29EE30B80703Q36714031-060386B7-AA86-4F23-9AD9-370838625E5FQ36827878-6CE0CDE7-D125-449F-BBCE-4E68857FDCC0Q37076037-6A3A41FA-6E64-4DA6-8038-931C6528073BQ37310131-E60EF627-6340-4A49-A504-1B98F7E586DDQ37434694-71FE1871-9FD3-4BE0-9F71-635381975DECQ37633794-E6E57F08-672C-4F81-BD76-A6E6EED7DA9BQ37721784-3B36C967-5FDD-42BD-AB7A-A9275F290B5AQ38637363-71EBB99C-B71A-48BE-BC94-1A73EE392DDCQ38689595-962769A3-8261-47A2-80B8-FAC91C68E3C7Q38701617-EC8F5742-B4E5-4514-8DD2-495FF6E78711Q38785297-C365AC74-0CDB-4B97-BD73-2C982951E348Q38836985-491100E6-E2FD-4EC7-9211-755B0DAB061FQ38918147-CA5A83FD-013F-4427-91F8-3523643EF540Q39186198-970142E1-D577-49B1-94FF-7C77E73F2F5CQ39381331-4AF9AE8E-DB2F-42FC-8B69-2CDD952846DDQ39453162-AFAED1D6-ADCF-4FA9-93E9-23C79C6B51C2Q39459129-205C088E-4AA4-4AB0-99EE-1AE41DF92AC6Q40079055-9546C387-B439-4276-B409-9691DE3A4016Q40345971-28368AE5-C4A9-4725-9873-F7833FA476C1Q40914356-F7E5E221-8B68-4DC8-A2E2-5FD5CDA544D5Q41686252-FC47E89F-20CC-4569-8B23-6160A1FD56A7Q42373443-E5A915BD-8907-4649-8B45-3E731DBA61D4Q45061812-9E25D75E-A0B5-4E1D-98A2-7BFD05CE29BDQ45849451-654B511A-A4F0-429E-B7F2-1CBA85EF73BCQ46227294-03967263-8125-4836-A331-C336112BAFE3
P2860
Microbiota-dependent metabolite trimethylamine-N-oxide is associated with disease severity and survival of patients with chronic heart failure.
description
2014 nî lūn-bûn
@nan
2014 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Microbiota-dependent metabolit ...... ts with chronic heart failure.
@ast
Microbiota-dependent metabolit ...... ts with chronic heart failure.
@en
type
label
Microbiota-dependent metabolit ...... ts with chronic heart failure.
@ast
Microbiota-dependent metabolit ...... ts with chronic heart failure.
@en
prefLabel
Microbiota-dependent metabolit ...... ts with chronic heart failure.
@ast
Microbiota-dependent metabolit ...... ts with chronic heart failure.
@en
P2093
P2860
P50
P356
P1476
Microbiota-dependent metabolit ...... ts with chronic heart failure.
@en
P2093
B Bjørndal
I Gregersen
T H Karlsen
P2860
P304
P356
10.1111/JOIM.12328
P407
P577
2014-12-01T00:00:00Z